315 related articles for article (PubMed ID: 21614002)
1. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.
Lee JM; Lee YK; Mamrosh JL; Busby SA; Griffin PR; Pathak MC; Ortlund EA; Moore DD
Nature; 2011 May; 474(7352):506-10. PubMed ID: 21614002
[TBL] [Abstract][Full Text] [Related]
2. A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'?
Anstee QM; Day CP
J Hepatol; 2012 Apr; 56(4):987-9. PubMed ID: 22015962
[TBL] [Abstract][Full Text] [Related]
3. Metabolism: A lipid for fat disorders.
Ingraham HA
Nature; 2011 Jun; 474(7352):455-6. PubMed ID: 21697939
[No Abstract] [Full Text] [Related]
4. The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis.
Hochrath K; Krawczyk M; Goebel R; Langhirt M; Rathkolb B; Micklich K; Rozman J; Horsch M; Beckers J; Klingenspor M; Fuchs H; Gailus-Durner V; Wolf E; Acalovschi M; Volmer DA; Hrabě de Angelis M; Lammert F
FASEB J; 2012 Dec; 26(12):5081-91. PubMed ID: 22982378
[TBL] [Abstract][Full Text] [Related]
5. Liver receptor homolog-1 is critical for adequate up-regulation of Cyp7a1 gene transcription and bile salt synthesis during bile salt sequestration.
Out C; Hageman J; Bloks VW; Gerrits H; Sollewijn Gelpke MD; Bos T; Havinga R; Smit MJ; Kuipers F; Groen AK
Hepatology; 2011 Jun; 53(6):2075-85. PubMed ID: 21391220
[TBL] [Abstract][Full Text] [Related]
6. Perilipin 5 is a novel target of nuclear receptor LRH-1 to regulate hepatic triglycerides metabolism.
Pantha R; Lee JH; Bae JH; Koh EH; Shin M; Song DK; Im SS
BMB Rep; 2021 Sep; 54(9):476-481. PubMed ID: 34488925
[TBL] [Abstract][Full Text] [Related]
7. LRH-1-dependent glucose sensing determines intermediary metabolism in liver.
Oosterveer MH; Mataki C; Yamamoto H; Harach T; Moullan N; van Dijk TH; Ayuso E; Bosch F; Postic C; Groen AK; Auwerx J; Schoonjans K
J Clin Invest; 2012 Aug; 122(8):2817-26. PubMed ID: 22772466
[TBL] [Abstract][Full Text] [Related]
8. LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity.
Miranda DA; Krause WC; Cazenave-Gassiot A; Suzawa M; Escusa H; Foo JC; Shihadih DS; Stahl A; Fitch M; Nyangau E; Hellerstein M; Wenk MR; Silver DL; Ingraham HA
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515023
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.
Musille PM; Pathak M; Lauer JL; Hudson WH; Griffin PR; Ortlund EA
Nat Struct Mol Biol; 2012 Apr; 19(5):532-S2. PubMed ID: 22504882
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.
Singh AB; Dong B; Xu Y; Zhang Y; Liu J
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):358-371. PubMed ID: 30580099
[TBL] [Abstract][Full Text] [Related]
11. Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes.
Miao J; Choi SE; Seok SM; Yang L; Zuercher WJ; Xu Y; Willson TM; Xu HE; Kemper JK
Mol Endocrinol; 2011 Jul; 25(7):1159-69. PubMed ID: 21566081
[TBL] [Abstract][Full Text] [Related]
12. FXR an emerging therapeutic target for the treatment of atherosclerosis.
Mencarelli A; Fiorucci S
J Cell Mol Med; 2010 Jan; 14(1-2):79-92. PubMed ID: 20041971
[TBL] [Abstract][Full Text] [Related]
13. [New pathophysiological mechanisms of metabolic syndrome: implication of orphan nuclear receptors?].
Kuhn E; Fève B; Lombès M
Ann Endocrinol (Paris); 2012 Oct; 73 Suppl 1():S9-16. PubMed ID: 23089382
[TBL] [Abstract][Full Text] [Related]
14. Resistance of SHP-null mice to bile acid-induced liver damage.
Wang L; Han Y; Kim CS; Lee YK; Moore DD
J Biol Chem; 2003 Nov; 278(45):44475-81. PubMed ID: 12933814
[TBL] [Abstract][Full Text] [Related]
15. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
16. Liver receptor homolog-1, an emerging metabolic modulator.
Lee YK; Moore DD
Front Biosci; 2008 May; 13():5950-8. PubMed ID: 18508634
[TBL] [Abstract][Full Text] [Related]
17. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
19. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters.
Zhang YK; Guo GL; Klaassen CD
PLoS One; 2011 Feb; 6(2):e16683. PubMed ID: 21346810
[TBL] [Abstract][Full Text] [Related]
20. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
